AtkinsRéalis Group (ATRL) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
2 Dec, 2025Executive summary
Achieved record revenue and Segment Adjusted EBIT in 2024, driven by strong demand in nuclear and engineering services, and completed the "Pivoting to Growth" strategy, meeting or exceeding all targets.
Announced sale of entire 6.76% interest in Highway 407 for ~$2.8 billion, a key step in strategic simplification and value creation.
Major contract wins in nuclear, including the first CANDU® new build since 2007 and significant life extension projects in Romania and Canada.
Organizational changes include COO transition, new structure for Engineering Services, and strengthening of engineering and nuclear teams.
Positive net cash from operating activities and reduced leverage, with a leverage ratio of 1.1x at year-end.
Financial highlights
Record 2024 revenue of $9.7 billion, up 12% year-over-year; services revenue up 16%.
Segment-adjusted EBIT rose 10% to $845 million; adjusted net income from PSMPM up 15% to $315 million.
Net cash from operating activities was $526 million, a significant increase from $66 million in 2023.
Adjusted EPS from PSMPM was $1.79 per diluted share for the year.
Backlog reached a record $17.5 billion, up 24% year-over-year.
Outlook and guidance
2025 organic revenue growth for engineering services regions expected at 7-9%, with segment-adjusted EBITDA margin of 16-17%.
Nuclear segment revenue guidance for 2025 is $1.6-$1.7 billion, with adjusted EBIT margin of 12-14%.
Operating cash flow for 2025 expected to exceed $300 million, with higher CapEx of $150-$200 million focused on Monarch nuclear reactor development.
2025-2027 targets include >8% organic revenue CAGR for Engineering Services Regions and 17-18% EBITDA margin by 2027.
Dividend maintained at $0.02 per share for Q1 2025.
Latest events from AtkinsRéalis Group
- Record revenue, earnings, and backlog in 2025 set the stage for continued growth in 2026.ATRL
Q4 202527 Feb 2026 - Targeting >8% organic growth, margin expansion, and nuclear leadership with disciplined capital allocation.ATRL
Investor Day 20243 Feb 2026 - Record backlog, double-digit growth, and upgraded nuclear outlook highlight Q2 2024.ATRL
Q2 20241 Feb 2026 - Q3 2024 delivered record Nuclear backlog, margin gains, and robust cash flow generation.ATRL
Q3 202414 Jan 2026 - Q2 2025 saw record backlog, 15% revenue growth, and a $2.32B net income surge.ATRL
Q2 202523 Nov 2025 - Record backlog and surging Nuclear growth drive raised outlook and strong Q1 2025 results.ATRL
Q1 202519 Nov 2025 - Q3 2025 saw double-digit revenue and EPS growth, record backlog, and raised Nuclear guidance.ATRL
Q3 202513 Nov 2025